Description
What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We're focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases. We're looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before. Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world? If the answer is yes, then Editas Medicine is the place for you.
Key Responsibilities & Accountabilities:
* Develop, qualify and execute biomarker assays with most appropriate technical platforms in order to advance immune-oncology, hemotology or other therapeutic pipeline to the clinic.
* Design, execute, interpret and report clinical endpoint assays with primary tissues for clinical development.
* Interact with clinical team, internal stakeholders and external partners to develop strategy for biomarker plan for new programs in the pipeline and transfer assays in support of clinical trial.
* Be able to follow the relevant FDA guideline to develop and qualify the assay with consistent quality in proceed development and execution of the studies
* Prepare and review reports and packages for regulatory submissions.
* Assist in development of immune-oncology, hemotology or other therapeutic biomarker, clinical endpoint strategy and differentiation.
* Lead, mentor and manage direct reports and other team members in the area of biomarker strategy, development and qualification.
